Cancer and blood cancer: which conditions have an open charitable copay fund

Conditions in this group

• Ovarian Cancer4 open, 1 not open, of 5 funds; 2 drugs named on FDA labels
• Chronic Lymphocytic Leukemia3 open, 1 not open, of 4 funds; 5 drugs named on FDA labels
• Acute Myeloid Leukemia2 open, 2 not open, of 4 funds; 5 drugs named on FDA labels
• Waldenstrom Macroglobulinemia2 open, 1 not open, of 3 funds
• Mantle Cell Lymphoma2 open, 0 not open, of 2 funds; 4 drugs named on FDA labels
• Multiple Myeloma1 open, 5 not open, of 6 funds; 5 drugs named on FDA labels
• Myelodysplastic Syndrome1 open, 4 not open, of 5 funds
• Acute Lymphoblastic Leukemia1 open, 3 not open, of 4 funds; 2 drugs named on FDA labels
• Renal Cell Carcinoma1 open, 3 not open, of 4 funds; 4 drugs named on FDA labels
• Gastrointestinal stromal tumor1 open, 2 not open, of 3 funds; 2 drugs named on FDA labels
• Myeloproliferative neoplasms1 open, 2 not open, of 3 funds
• Cervical Cancer1 open, 1 not open, of 2 funds
• Merkel Cell Carcinoma1 open, 1 not open, of 2 funds
• Follicular lymphoma1 open, 0 not open, of 1 fund; 2 drugs named on FDA labels
• Philadelphia chromosome negative myeloproliferative neoplasms1 open, 0 not open, of 1 fund
• Non-Small Cell Lung Cancer0 open, 6 not open, of 6 funds; 10 drugs named on FDA labels
• Chronic Myeloid Leukemia0 open, 5 not open, of 5 funds; 4 drugs named on FDA labels
• Breast Cancer0 open, 4 not open, of 4 funds; 10 drugs named on FDA labels
• Metastatic Colorectal Cancer0 open, 4 not open, of 4 funds; 6 drugs named on FDA labels
• Non-Hodgkin Lymphoma0 open, 4 not open, of 4 funds
• Pancreatic Cancer0 open, 4 not open, of 4 funds; 1 drug named on FDA labels
• Prostate Cancer0 open, 4 not open, of 4 funds; 8 drugs named on FDA labels
• Small Cell Lung Cancer0 open, 4 not open, of 4 funds
• Bone Metastases0 open, 3 not open, of 3 funds; 1 drug named on FDA labels
• Melanoma0 open, 3 not open, of 3 funds; 5 drugs named on FDA labels
• Metastatic Breast Cancer0 open, 3 not open, of 3 funds; 8 drugs named on FDA labels
• Uterine cancer0 open, 3 not open, of 3 funds
• Bladder Cancer0 open, 2 not open, of 2 funds
• Chemotherapy Induced Neutropenia0 open, 2 not open, of 2 funds
• Colorectal cancer0 open, 2 not open, of 2 funds; 6 drugs named on FDA labels
• Gastric Cancer0 open, 2 not open, of 2 funds; 1 drug named on FDA labels
• Glioblastoma0 open, 2 not open, of 2 funds
• Head and Neck Cancer0 open, 2 not open, of 2 funds
• Hepatocellular Carcinoma0 open, 2 not open, of 2 funds; 3 drugs named on FDA labels
• Hodgkin Lymphoma0 open, 2 not open, of 2 funds; 1 drug named on FDA labels
• Liver Cancer0 open, 2 not open, of 2 funds
• Metastatic Melanoma0 open, 2 not open, of 2 funds; 5 drugs named on FDA labels
• Metastatic Prostate Cancer0 open, 2 not open, of 2 funds
• Neuroendocrine Tumors0 open, 2 not open, of 2 funds; 2 drugs named on FDA labels
• Soft Tissue Sarcoma0 open, 2 not open, of 2 funds
• Acute Leukemia in Pediatrics, Adolescents & Young Adults0 open, 1 not open, of 1 fund
• Anal Cancer0 open, 1 not open, of 1 fund
• Anaplastic Large Cell Lymphoma0 open, 1 not open, of 1 fund
• B-Cell Lymphoma0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Basal cell carcinoma0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Biliary tract cancer0 open, 1 not open, of 1 fund
• Bladder and Urothelial Cancer0 open, 1 not open, of 1 fund
• Blastic Plasmacytoid Dendritic Cell Neoplasm0 open, 1 not open, of 1 fund
• Carcinoid Tumors and Associated Symptoms0 open, 1 not open, of 1 fund
• Chemotherapy Induced Nausea or Vomiting0 open, 1 not open, of 1 fund
• Cholangiocarcinoma0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Desmoid Tumor0 open, 1 not open, of 1 fund
• Diffuse large B-cell lymphoma0 open, 1 not open, of 1 fund
• Esophageal Cancer0 open, 1 not open, of 1 fund
• Glioblastoma Multiforme/Anaplastic Astrocytoma0 open, 1 not open, of 1 fund
• Malignant Mesothelioma0 open, 1 not open, of 1 fund
• Medullary Thyroid Cancer0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Metastatic Castrate Resistant Prostate Cancer0 open, 1 not open, of 1 fund
• Metastatic Differentiated Thyroid Cancer0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Metastatic gastric cancer0 open, 1 not open, of 1 fund; 1 drug named on FDA labels
• Metastatic Pheochromocytoma and Paraganglioma0 open, 1 not open, of 1 fund
• Metastatic Skin Cancer - Non Melanoma0 open, 1 not open, of 1 fund
• Pancreatic Neuroendocrine Tumor0 open, 1 not open, of 1 fund
• Skin cancer0 open, 1 not open, of 1 fund
• Thyroid cancer0 open, 1 not open, of 1 fund; 5 drugs named on FDA labels
• Wilms' Tumor0 open, 1 not open, of 1 fund

Questions